Orchard Therapeutics

@orchard_tx

Dedicated to transforming the lives of patients with inherited diseases through innovative gene therapy.

Vrijeme pridruživanja: siječanj 2017.

Tweetovi

Blokirali ste korisnika/cu @orchard_tx

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @orchard_tx

  1. 3. velj

    As investigational cell and gene therapies advance, biotech companies are working with industry stakeholders to find agreeable payment models. Orchard’s Francis Pang will join a panel at Congress to discuss this value-based approach. Agenda here:

    Poništi
  2. 3. velj

    PRESS RELEASE: Orchard Therapeutics Appoints Industry Veteran Steven Altschuler, M.D. to its Board of Directors. Learn more:

    Poništi
  3. 1. velj

    Every day, we are inspired to work alongside the rare disease community. Throughout this month we’ll be honoring and the more than 300 million people worldwide living with a . See how you can get involved:

    Poništi
  4. 31. sij

    Hello from 101 Seaport Boulevard! We’re excited to announce we’ve relocated our U.S. headquarters in Boston to a new office in the dynamic district.

    Poništi
  5. 29. sij

    PRESS RELEASE: Orchard Therapeutics Announces FDA Granted Orphan Drug Designation for OTL-102 for the Treatment of X-linked Chronic Granulomatous Disease (X-CGD). Learn more:

    Poništi
  6. 28. sij

    Our President of Research & Chief Scientific Officer, , will join today's webinar on best practices for managing a pivotal trial. will moderate. Register now:

    Poništi
  7. 23. sij

    Sue Rogers, Orchard’s vice president of global distribution, patient access & support services, spoke at the Leaders World 2020 event. Thank you to for the opportunity to share our insights.

    Poništi
  8. 20. sij

    Fresh out of J.P. Morgan, our team is energized by our time at and remains committed to bringing the potential benefits of gene therapy to those who could benefit. We look forward to carrying this mission ahead into this .

    Poništi
  9. 15. sij

    For children born with , early diagnosis is critical to improving treatment outcomes. The recently released a booklet on the importance of for ADA-SCID and other forms of SCID. Read the full booklet:

    Poništi
  10. 14. sij

    Today, Orchard’s president and CEO, Mark Rothera, will present at the J.P. Morgan Healthcare Conference at 11:30 a.m. PST. We can’t wait to share our story, our progress and our plans for the year ahead.

    Poništi
  11. 13. sij

    PRESS RELEASE: Orchard Therapeutics Highlights 2020 Strategic Priorities. Learn more:

    Poništi
  12. 9. sij

    Our platform for our investigational therapies is based on our ex vivo autologous approach which relies on the intrinsic ability of blood stem cells to self-renew in a patient’s bone marrow and potentially produce new blood cells of all types:

    Poništi
  13. 7. sij

    We are part of gene therapy history – and its future. Today, we are proud to launch our new corporate branding and website that celebrates this rich history and expresses our mission to bring one-time, potentially curative GTs to people with rare diseases:

    Poništi
  14. 6. sij

    Our team will start 2020 by attending the J.P. Morgan Healthcare Conference in San Francisco. We look forward to kicking off a new year of innovation and inspiration with you at .

    Poništi
  15. 6. sij

    PRESS RELEASE: Orchard Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference. Learn more:

    Poništi
  16. 2. sij

    We were pleased to connect with so many of our colleagues in the hematology community at . Our team was proud to host many of you at the Orchard booth and to share our exciting progress across multiple programs.

    Poništi
  17. 31. pro 2019.

    As we ring in the New Year, we wish you health, happiness and limitless imagination in 2020.

    Poništi
  18. 26. pro 2019.

    Manufacturing capability is key to delivering potentially life-changing gene therapies. Orchard’s CTO, Ran Zheng, recently spoke with about biopharma manufacturing trends to watch in 2020 and beyond. Read the full interview:

    Poništi
  19. 24. pro 2019.

    Happy Holidays from our team at Orchard! Wherever you are in the world, we hope you enjoy the company of your loved ones this holiday season.

    Poništi
  20. 20. pro 2019.

    We’re proud to support Cure MLD in their tireless efforts to help families impacted by . This global network of patient advocates and nonprofits provides families with resources, information, support.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·